Access the full text.
Sign up today, get DeepDyve free for 14 days.
Erich Wedam, G. Bigelow, Rolley Johnson, Paul Nuzzo, M. Haigney (2007)
QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial.Archives of internal medicine, 167 22
Ying Han, Wei Yan, Yong-Bo Zheng, M. Khan, K. Yuan, Lin Lu (2019)
The rising crisis of illicit fentanyl use, overdose, and potential therapeutic strategiesTranslational Psychiatry, 9
P. Whelan, Kimberly Remski (2012)
Buprenorphine vs methadone treatment: A review of evidence in both developed and developing worldsJournal of Neurosciences in Rural Practice, 3
Denis Antoine, A. Huhn, E. Strain, Gavin Turner, Jasmyne Jardot, A. Hammond, K. Dunn (2020)
Method for Successfully Inducting Individuals Who Use Illicit Fentanyl Onto Buprenorphine/Naloxone.The American journal on addictions
R. Brar, N. Fairbairn, Christy Sutherland, S. Nolan (2020)
Use of a novel prescribing approach for the treatment of opioid use disorder: Buprenorphine/naloxone micro-dosing - a case series.Drug and alcohol review, 39 5
D. Saal, F. Lee (2020)
Rapid Induction Therapy for Opioid-Use Disorder Using Buprenorphine Transdermal Patch: A Case Series.The Permanente journal, 24
Ashraf Amlani, G. Mckee, N. Khamis, Geetha Raghukumar, Erica Tsang, J. Buxton (2015)
Why the FUSS (Fentanyl Urine Screen Study)? A cross-sectional survey to characterize an emerging threat to people who use drugs in British Columbia, CanadaHarm Reduction Journal, 12
Colleen Barry (2018)
Fentanyl and the Evolving Opioid Epidemic: What Strategies Should Policy Makers Consider?Psychiatric services, 69 1
J. Aquino, Suprit Parida, M. Sofuoglu (2021)
The Pharmacology of Buprenorphine Microinduction for Opioid Use DisorderClinical Drug Investigation, 41
J. Aquino, C. Fairgrieve, Sukhpreet Klaire, Gabriela Garcia-Vassallo (2020)
Rapid Transition From Methadone to Buprenorphine Utilizing a Micro-dosing Protocol in the Outpatient Veteran Affairs SettingJournal of Addiction Medicine, 14
S. Silverstein, Raminta Daniulaityte, S. Martins, Shannon Miller, R. Carlson (2019)
"Everything is not right anymore": Buprenorphine experiences in an era of illicit fentanyl.The International journal on drug policy, 74
S. Mercadante (2011)
The use of rapid onset opioids for breakthrough cancer pain: the challenge of its dosing.Critical reviews in oncology/hematology, 80 3
W. White, M. Campbell, R. Spencer, H. Hoffman, Brian Crissman, R. Dupont (2014)
Patterns of Abstinence or Continued Drug Use Among Methadone Maintenance Patients and Their Relation to Treatment RetentionJournal of Psychoactive Drugs, 46
R. Hämmig, A. Kemter, Johannes Strasser, U. Bardeleben, B. Gugger, M. Walter, K. Dürsteler, M. Vogel (2016)
Use of microdoses for induction of buprenorphine treatment with overlapping full opioid agonist use: the Bernese methodSubstance Abuse and Rehabilitation, 7
Jonathan Robbins, Honora Englander, J. Gregg (2021)
Buprenorphine Microdose Induction for the Management of Prescription Opioid Dependence.Journal of the American Board of Family Medicine : JABFM, 34 Supplement
J. Gagnier, G. Kienle, D. Altman, D. Moher, H. Sox, David Riley (2013)
The CARE guidelines: consensus-based clinical case reporting guideline developmentBMJ Case Reports, 2013
M. Weimer, Michael Guerra, Gina Morrow, K. Adams (2020)
Hospital-based Buprenorphine Micro-dose InitiationJournal of Addiction Medicine, 15
S. Arunogiri, S. Nielsen (2020)
Opioid agonist treatment in the time of fentanyl: What can we learn from emerging evidence?Drug and alcohol review
D. Ciccarone, Jeff Ondocsin, S. Mars (2017)
Heroin uncertainties: Exploring users' perceptions of fentanyl-adulterated and -substituted 'heroin'.The International journal on drug policy, 46
Abstract Introduction The micro-induction method of initiating buprenorphine is becoming a popular method for initiating buprenorphine in patients with Opioid Use Disorder, who are on full opioid agonists, either prescribed or non-prescribed, in order to avoid precipitated withdrawal. Given the rising concerns around illicit fentanyl use, this method of initiating buprenorphine has become another tool for clinicians to help patients with Opioid Use Disorder, even when multiple full opioid agonists are involved. While the process for initiating buprenorphine through this process is well studied, the characteristics of patients who are able to tolerate this initiation method in an outpatient setting is not. Case(s) We present the cases of two patients with Opioid Use Disorder in a community-based methadone maintenance program in whom micro-induction methods were used to initiate buprenorphine without lowering the methadone dose. Both patients successfully transitioned to buprenorphine without precipitated withdrawal. One of the patients was also using fentanyl at the time of induction and was able to abstain from fentanyl use following the induction process. Conclusion Initiating Buprenorphine using micro-induction strategies in a community based outpatient clinic in patients who are already on full opioid agonists is feasible, in these particular cases, the methadone dose or concurrent fentanyl use did not affect the outcome. We present the characteristics of the patient and the community clinic hoping that this helps more clinicians in replicating this induction strategy.
Journal of Addictive Diseases – Taylor & Francis
Published: Apr 3, 2023
Keywords: Case report; microinduction; buprenorphine; fentanyl; methadone
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.